Efficacy of Minocycline in Depression: A Systematic Review and Meta-analysis
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objectives: Traditional antidepressant therapy is associated with an inadequate response and a low remission rate. Our aim was to synthesize published randomized controlled trials on the potential effects of minocycline in patients with depression. Methods: PubMed, Web of Science, Embase, and Cochrane Library databases were searched for studies published. Randomized controlled trials published in English that evaluated the efficacy of minocycline in patients with depression were selected for inclusion. Changes from baseline in the Hamilton Depression Rating Scale (HDRS) or Montgomery-Åsberg Depression Rating Scale (MADRS) were pooled to determine the antidepressant effect of minocycline compared with placebo. The quality of the included studies was assessed using the Cochrane risk-of-bias tool. Results: Eight trials with 567 participants were eligible and included in the analysis. The meta-analysis did not reveal a statistically significant effect of minocycline on depression based on HDRS or MADRS scores. Conclusions: According to the HDRS and MADRS scores, minocycline did not demonstrate effectiveness in reducing depressive symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A 2025 systematic review of minocycline in depression and related neuroinflammatory conditions [66] further characterized the evidence base and identified biomarker enrichment as the key moderator of treatment response.”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Nettis, M. A., Lombardo, G., Hastings, C., Zajkowska, Z., Mariani, N., Nikkheslat, N., Worrell, C., Enache, D., McLaughlin, A., Kose, M., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00948-6 · Cited by 235
Dhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225
Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199
Husain, M. I., Chaudhry, I. B., Khoso, A. B., Husain, M. O., Hodsoll, J., Ansari, M. A., Naqvi, H. A., Minhas, F. A., Carvalho, A. F., Meyer, J. H., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30138-3 · Cited by 167
Research works printed but not linked: 23
- 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 · DOI · Paper page
- 2020, Red and processed meat consumption and risk of depression: a systematic review and meta-analysis, Int J Environ Res Public Health, 17, 6686, 10.3390/ijerph17186686 · DOI
- 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9 · DOI · Paper page
- 2019, The role of inflammation in depression and fatigue, Front Immunol, 10, 1696, 10.3389/fimmu.2019.01696 · DOI · Paper page
- 2009, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol Psychiatry, 65, 732, 10.1016/j.biopsych.2008.11.029 · DOI · Paper page
- 2019, Inflammatory profiles of severe treatment-resistant depression, J Affect Disord, 246, 42, 10.1016/j.jad.2018.12.037 · DOI · Paper page
- 2024, Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review, Naunyn Schmiedebergs Arch Pharmacol, 397, 2835, 10.1007/s00210-023-02839-1 · DOI
- 2020, Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future, J Glob Antimicrob Resist, 22, 161, 10.1016/j.jgar.2020.01.022 · DOI
- 2015, NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism, Behav Brain Res, 287, 89, 10.1016/j.bbr.2015.03.023 · DOI
- 2015, Randomized proof of concept trial of GLYX-13, an N-methyl-d-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent, J Psychiatr Pract, 21, 140, 10.1097/01.pra.0000462606.17725.93 · DOI · Paper page
- 2022, Is minocycline effective for treating depression?, JAAPA, 35, 13, 10.1097/01.JAA.0000824988.46634.1d · doi:10.1097/01.jaa.0000824988.46634.1d
- 2019, Positive and negative allosteric modulators of N-methyl-d-aspartate (NMDA) receptors: structure-activity relationships and mechanisms of action, J Med Chem, 62, 3, 10.1021/acs.jmedchem.7b01640 · DOI
- 2018, Anti-inflammatory effects of minocycline are mediated by retinoid signaling, BMC Neurosci, 19, 58, 10.1186/s12868-018-0460-x · DOI
- 2018, Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials, J Affect Disord, 227, 219, 10.1016/j.jad.2017.10.042 · DOI · Paper page
- 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097 · DOI · Paper page
- 2017, Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial, Aust N Z J Psychiatry, 51, 829, 10.1177/0004867417709357 · DOI · Paper page
- 2016, Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial, Int Clin Psychopharmacol, 31, 20, 10.1097/YIC.0000000000000098 · DOI
- 2017, Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial, J Psychopharmacol, 31, 1166, 10.1177/0269881117724352 · DOI · Paper page
- 2018, Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial, Transl Psychiatry, 8, 27, 10.1038/s41398-017-0073-7 · DOI · Paper page
- 2021, A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder, Transl Psychiatry, 11, 334, 10.1038/s41398-021-01450-3 · DOI
- 2014, Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment, J Neurovirol, 20, 620, 10.1007/s13365-014-0292-0 · DOI
- 2014, C-reactive protein and depression in persons with human immunodeficiency virus infection: the Positive Living with HIV (POLH) Study, Brain Behav Immun, 42, 89, 10.1016/j.bbi.2014.06.004 · DOI
- 2003, Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells, Cardiovasc Res, 59, 755, 10.1016/S0008-6363(03)00515-7 · DOI · Paper page
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Huang, H., Zou, Z., & Chen, B.
- Venue
- Clinical Neuropharmacology
- Published
- 2024-11-25
- Volume
- 48
- Issue
- 1
- Pages
- 1-6
- ISSN
- 1537-162X
- 0362-5664
- Cited by
- 5
- References
- 13
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Minocycline in Depression: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.1097/wnf.0000000000000618
- The paper
- Huang, H., Zou, Z., & Chen, B. (2025). Efficacy of Minocycline in Depression: A Systematic Review and Meta-analysis. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000618
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.